Reconstruction of hand surgical wounds after correction of pseudo-syndactyly or squamous cell carcinoma resection in patients affected from epidermolysis bullosa: a monocentric experience with a collagen-elastin dermal matrix dermal substitute
https://doi.org/10.4081/dr.2024.10016
Accepted: 16 June 2024
All claims expressed in this article are solely those of the authors and do not necessarily represent those of their affiliated organizations, or those of the publisher, the editors and the reviewers. Any product that may be evaluated in this article or claim that may be made by its manufacturer is not guaranteed or endorsed by the publisher.
In patients with Epidermolysis Bullosa (EB), surgery may be required to remove Squamous Cell Carcinoma (SCC) of the hands or to correct pseudo-syndactyly. Dermal substitutes may represent a suitable tool to promote the healing of surgical wounds in EB. We review our experience with a collagen-elastin dermal matrix to promote surgical wound healing due to hand surgery to correct pseudo-syndactyly or SCC resection in patients affected by EB.
Overall, 12 patients (mean age, 29±11 years, range 13-51; four females) with EB were considered, with a total of 25 different interventions (16 SCC removals; three amputations for recurrent infiltrating SCC; six pseudo-syndactyly corrections). All patients received a collagen-elastin dermal matrix sheet. Neodermis was achieved in all patients, and no adverse events potentially associated with the graft occurred. No SCC recurrence was reported at sites operated for either SCC resection or amputation. The opening of the first or second commissure appears to be maintained for over 1 year after the procedure, preserving digital function.
We believe that the application of a dermal substitute, together with a close dressing protocol, may represent a suitable strategy for obtaining physiological tissue regeneration and maintaining proper hand function in patients with EB.
Natsuga K, Shinkuma S, Hsu CK, et al. Current topics in epidermolysis bullosa: pathophysiology and therapeutic challenges. J Dermatol Sci. 2021;104:164-76. DOI: https://doi.org/10.1016/j.jdermsci.2021.11.004
Box R, Bernardis C, Pleshkov A, et al. Hand surgery and hand therapy clinical practice guideline for epidermolysis bullosa. Orphanet J Rare Dis. 2022;17:406. DOI: https://doi.org/10.1186/s13023-022-02282-0
du Rand A, Hunt JMT, Feisst V, Sheppard HM. epidermolysis bullosa: a review of the tissue-engineered skin substitutes used to treat wounds. Mol Diagn Ther. 2022;26:627-43. DOI: https://doi.org/10.1007/s40291-022-00613-2
Abboud L, Leclerc-Mercier S, Bodemer C, Guéro S. Hand surgery in recessive dystrophic epidermolysis bullosa: our experience with dermal substitutes. J Plast Reconstr Aesthet Surg. 2022;75:314-24. DOI: https://doi.org/10.1016/j.bjps.2021.05.056
Condorelli AG, Dellambra E, Logli E, et al. epidermolysis bullosa-associated squamous cell carcinoma: from pathogenesis to therapeutic perspectives. Int J Mol Sci. 2019;20:5707. DOI: https://doi.org/10.3390/ijms20225707
Paganelli A, Reggiani C, Fiorentini C, et al. Surgical management of squamous cell carcinoma arising in patients affected by epidermolysis bullosa: a comparative study. Int Wound J. 2020;17:519-21. DOI: https://doi.org/10.1111/iwj.13306
Rotschein P, Vokurková J, Bučková H. Surgical treatment and management of cutaneous squamous cell carcinoma in patients with dystrophic epidermolysis bullosa - a case report. Acta Chir Plast. 2021;63:196-200. DOI: https://doi.org/10.48095/ccachp2021196
Tchero H, Herlin C, Bekara F, et al. Failure rates of artificial dermis products in treatment of diabetic foot ulcer: A systematic review and network meta-analysis. Wound Repair Regen. 2017;25:691-6. DOI: https://doi.org/10.1111/wrr.12554
Dickson K, Lee KC, Abdulsalam A, et al. A Histological and clinical study of MatriDerm® use in burn reconstruction. J Burn Care Res. 2023:irad024. DOI: https://doi.org/10.1093/jbcr/irad024
Hones KM, Hones J, Satteson ES, Chim H. Treatment of complex extremity wounds with MatriDerm: first clinical experience in the US. J Wound Care. 2023;32:167-71. DOI: https://doi.org/10.12968/jowc.2023.32.3.167
Paganelli A, Naselli AG, Bertoni L, et al. Wound healing after acellular dermal substitute positioning in dermato-oncological surgery: a prospective comparative study. Life (Basel). 2023;13:463. DOI: https://doi.org/10.3390/life13020463
Salloum A, Bazzi N, Squires S, et al. Comparing the application of various engineered xenografts for skin defects: a systematic review. J Cosmet Dermatol. 2023;22:921-31. DOI: https://doi.org/10.1111/jocd.15517
De Angelis B, Gentile P, Agovino A, et al. Chronic ulcers: MATRIDERM(®) system in smoker, cardiopathic, and diabetic patients. J Tissue Eng. 2013;4:2041731413502663. DOI: https://doi.org/10.1177/2041731413502663
Mandel VD, Persechino F, Fiorentini C, et al. Treatment of chronic infected post-oncological wounds with a dermal matrix: two case studies. J Wound Care. 2018;27:558-62. DOI: https://doi.org/10.12968/jowc.2018.27.9.558
Abbate V, Iaconetta G, Sani L, et al. The use of dermal substitutes for donor site closure after radial forearm free flap harvesting. J Craniofac Surg. 2021;32:e205-8. DOI: https://doi.org/10.1097/SCS.0000000000006808
Campagnari M, Jafelicci AS, Carneiro HA, et al. Dermal substitutes use in reconstructive surgery for skin tumors: a single-center experience. Int J Surg Oncol. 2017;2017:9805980. DOI: https://doi.org/10.1155/2017/9805980
Charvillat O, Plancq MC, Haraux E, et al. Aplasia cutis congenita of both knees: a new therapeutic strategy. Arch Pediatr. 2020;27:277-80. DOI: https://doi.org/10.1016/j.arcped.2020.05.007
Duteille F, Truffandier MV, Perrot P. ‘Matriderm’ dermal substitute with split-thickness skin graft compared with full-thickness skin graft for the coverage of skin defects after surgical treatment of congenital syndactyly: results in 40 commissures. J Hand Surg Eur Vol. 2016;41:350-1. DOI: https://doi.org/10.1177/1753193415594101
Jackson SR, Roman S. matriderm and split skin grafting for full-thickness pediatric facial burns. J Burn Care Res. 2019;40:251-4. DOI: https://doi.org/10.1093/jbcr/irz006
Fulchignoni C, Rocchi L, Cauteruccio M, Merendi G. Matriderm dermal substitute in treating post traumatic hand's fingertip tissue loss. J Cosmet Dermatol. 2022;21:750-7. DOI: https://doi.org/10.1111/jocd.14115
Mellerio JE, Robertson SJ, Bernardis C, et al. Management of cutaneous squamous cell carcinoma in patients with epidermolysis bullosa: best clinical practice guidelines. Br J Dermatol. 2016;174:56-67. DOI: https://doi.org/10.1111/bjd.14104
Véliz S, Huber H, Yubero MJ, et al. Early teeth extraction in patients with generalized recessive dystrophic epidermolysis bullosa: a case series. Spec Care Dentist. 2020;40:561-5. DOI: https://doi.org/10.1111/scd.12515
Polizzi A, Santonocito S, Patini R, et al. Oral alterations in heritable epidermolysis bullosa: a clinical study and literature review. Biomed Res Int. 2022;2022:6493156. DOI: https://doi.org/10.1155/2022/6493156
van den Heuvel I, Gottschalk A, Langer M, et al. Feasibility, efficacy, and safety of ultrasound-guided axillary plexus blockade in pediatric patients with epidermolysis bullosa dystrophica. Paediatr Anaesth. 2016;26:405-8. DOI: https://doi.org/10.1111/pan.12860
Zhou X, Zhang Y, Zhao M, et al. Surgical management of hand deformities in patients with recessive dystrophic epidermolysis bullosa. J Plast Surg Hand Surg. 2020;54:33-9. DOI: https://doi.org/10.1080/2000656X.2019.1661846
Bellei B, Govoni FA, Bertozzi E, et al. Restoring full-thickness skin defects with a dermal regeneration template and dermal-epidermal cell suspension in a patient with junctional epidermolysis bullosa. Eur J Dermatol. 2020;30:3722. DOI: https://doi.org/10.1684/ejd.2020.3722
Supporting Agencies
This work was made possible by an unrestricted grant from MedSkin. This work is generated within ERN-Skin.Copyright (c) 2024 the Author(s)
This work is licensed under a Creative Commons Attribution-NonCommercial 4.0 International License.
PAGEPress has chosen to apply the Creative Commons Attribution NonCommercial 4.0 International License (CC BY-NC 4.0) to all manuscripts to be published.
Downloads
Citations
